Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa washington
  4. leukemia
Show results for
Products
Services

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Washington
Brands

  • sana
  • aptevo

Leukemia Equipment Supplied In Washington

5 equipment items found
In WashingtonAvailable In WashingtonNear Washington

Sana - Model SC291 (CD19) - T cells - Hypoimmune Technology: Donor-derived

Sana - Model SC291 (CD19) - T cells - Hypoimmune Technology: Donor-derived

Manufactured by:Sana Biotechnology   based inSeattle, WASHINGTON (USA)
Oncology: Non-Hodgkin lymphoma (NHL), Acute lymphoblastic leukemia (ALL), Chronic lymphocytic leukemia ...
CONTACT SUPPLIER

Sana - Model SC276 (CD22 (+CD19)) - T Cells - Hypoimmune Technology: Donor-derived

Sana - Model SC276 (CD22 (+CD19)) - T Cells - Hypoimmune Technology: Donor-derived

Manufactured by:Sana Biotechnology   based inSeattle, WASHINGTON (USA)
Oncology; Non-Hodgkin lymphoma (NHL), Acute lymphoblastic leukemia (ALL), Chronic lymphocytic leukemia ...
CONTACT SUPPLIER

Sana - Model SG295 (CD8/CD19) - T cells - Fusogen Technology

Sana - Model SG295 (CD8/CD19) - T cells - Fusogen Technology

Manufactured by:Sana Biotechnology   based inSeattle, WASHINGTON (USA)
Oncology: Non-Hodgkin lymphoma (NHL), Acute lymphoblastic leukemia (ALL), Chronic lymphocytic leukemia ...
CONTACT SUPPLIER

Sana - Model SG242 (CD4/CD19) - T cells - Fusogen Technology

Sana - Model SG242 (CD4/CD19) - T cells - Fusogen Technology

Manufactured by:Sana Biotechnology   based inSeattle, WASHINGTON (USA)
Oncology: Non-Hodgkin lymphoma (NHL), Acute lymphoblastic leukemia (ALL), Chronic lymphocytic leukemia ...
CONTACT SUPPLIER

Aptevo - Model APVO436 (anti-CD123 x anti-CD3) - Optimized ADAPTIR Bispecific Antibody

Aptevo - Model APVO436 (anti-CD123 x anti-CD3) - Optimized ADAPTIR Bispecific Antibody

Manufactured by:Aptevo Therapeutics   based inSeattle, WASHINGTON (USA)
APVO436 is an optimized ADAPTIR bispecific antibody candidate designed to redirect T-cell cytotoxicity through the dual targeting of CD3, a T-cell co-receptor that promotes cytotoxicity, and CD123, a cell surface receptor highly expressed in several hematological malignancies, including acute myeloid leukemia, acute lymphoblastic leukemia, hairy cell ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT